Tegaserod for the treatment of irritable bowel syndrome.

Pharmacology, Toxicology and Pharmaceutical Science

• Irritable Colon 100%
• Tegaserod 100%
• Placebo 21%
• Gastrointestinal Symptom 21%
• Symptom 15%
• Diarrhea 10%
• Tolerability 5%
• Population Study 5%
• Disease 5%
• Inflammatory Bowel Disease 5%
• Placebo-Controlled Study 5%
• Pathophysiology 5%
• Gastrointestinal Disease 5%
• Bloating 5%
• Partial Agonist 5%
• Number Needed to Harm 5%
• Constipation 5%
• Symptomatology 5%
• Abdominal Pain 5%
• Abdominal Discomfort 5%

Medicine and Dentistry

• Minimal Clinically Important Difference 5%